Dustin Deming, MD

Articles by Dustin Deming, MD

Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US

ByIbrahim Halil Sahin, MD,Yan Lin, PhD,Greg Yothers, PhD,Peter C. Lucas, MD, PhD,Dustin Deming, MD,Thomas J. George, MD,Scott Kopetz, MD, PhD,Christopher H. Lieu, MD,Arvind Dasari, MD, MS

October 14th 2022

Ibrahim Halil Sahin, MD, and colleagues, explore, the CIRCULATE-US (NRG-GI008; NCT05174169) investigating postoperative ctDNA dynamics in early-stage colon cancer for treatment selection.

Latest Updated Articles

Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US
October 14th 2022

Dustin Deming, MD

Articles by Dustin Deming, MD

Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Companion Diagnostic for Niraparib in Advanced Ovarian Cancer

NCCN Guidelines Add Novel Therapeutics to First-Line TNBC Armamentarium

Emerging Strategies in Prostate Cancer: Molecular Glues and T-Cell Engagers

Atirmociclib/Fulvestrant Improves PFS in HR+/HER2– Breast Cancer

FDA Grants Fast Track Designation to FG001 for High-Grade Glioma Surgery